![Michael H. Golden](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenance du réseau au premier degré de Michael H. Golden
Entité | Type d'entité | Industrie | |
---|---|---|---|
GlaxoSmithKline, Inc.
![]() GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada.
18
| Subsidiary | Pharmaceuticals: Major | 18 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Michael H. Golden via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
CDI CORP. | Personnel Services | Director/Board Member | |
IMMUNOGEN, INC. | Biotechnology | Director/Board Member | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
SAFEGUARD SCIENTIFICS, INC. | Investment Managers | Corporate Officer/Principal | |
Telios Pharmaceuticals, Inc.
![]() Telios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Integra LifeSciences Holdings Corp., Telios Pharmaceuticals, Inc. is a pharmaceutical company focused on research. The company is based in San Diego, CA. The company was founded by Iain David Dukes, Erkki Ruoslahti. Telios Pharmaceuticals was acquired by Integra LifeSciences Holdings Corp. on August 17, 1995 for $35 million. | Pharmaceuticals: Major | Founder | |
Avigen, Inc.
![]() Avigen, Inc. Medical SpecialtiesHealth Technology Avigen, Inc. produces and sells drugs, animal health products, and chemicals. The firm also develops and commercializes small molecules of therapeutics and biologics for use in the treatment of serious neurological and neuromuscular disorders. The company was founded in 1992 and is headquartered in La Jolla, CA. | Medical Specialties | Director/Board Member | |
Arrow International LLC
![]() Arrow International LLC Medical SpecialtiesHealth Technology Arrow International, Inc. manufactures disposable catheters and related products. Its products are used principally to access the central vascular system for administration of fluids, drugs, and blood products. The firm's products are also used for patient monitoring, diagnosis, and pain management. The company was founded in 1975 and is headquartered in Reading, PA. | Medical Specialties | Director/Board Member | |
MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
GNC Corp.
![]() GNC Corp. Food RetailRetail Trade GNC Corp. retails natural and specialty foods. Its nutritional-supplements retail chain devoted solely to items such as vitamins and dietary products. The company also has stores within Rite Aid drugstores and makes Rite Aid private-label products. It was founded in 1935 and is headquartered in Pittsburgh, PA. | Food Retail | Director/Board Member | |
NUPATHE INC | Medical Specialties | Director/Board Member Director/Board Member | |
GSK Equity Investments Ltd.
![]() GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Investment Managers | Private Equity Analyst Corporate Officer/Principal | |
University of Pennsylvania | College/University | Undergraduate Degree Corporate Officer/Principal | |
University of Bath | College/University | Undergraduate Degree | |
University of Oxford | College/University | Doctorate Degree | |
The American Institute of Certified Public Accountants
![]() The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
University of Leeds | College/University | Graduate Degree | |
Massachusetts Institute of Technology | College/University | Undergraduate Degree Doctorate Degree | |
The Pennsylvania State University | College/University | Undergraduate Degree | |
Ben Franklin Technology Partners /Ventures/
![]() Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Technology Partners /Ventures/ (Ben Franklin Tech Partners) is a venture Capital firm founded in 1982. The firm is headquartered in Philadelphia, Pennsylvania. | Investment Managers | Investment Committee Member Investment Committee Member | |
The Financial Executives Institute | Corporate Officer/Principal | ||
GNC HOLDINGS, INC. | Specialty Stores | Director/Board Member | |
Merck Research Laboratories Massachusetts LLC
![]() Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Corporate Officer/Principal | |
OrbiMed Advisors Private Equity
![]() OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor | |
Rhodes University | College/University | Undergraduate Degree | |
Themis Bioscience GmbH
![]() Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Director/Board Member | |
IOVANCE BIOTHERAPEUTICS, INC. | Biotechnology | Chairman | |
Corridor Pharmaceuticals, Inc.
![]() Corridor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corridor Pharmaceuticals, Inc. develops and manufactures biopharmaceutical products. The company was founded on February 1, 2008 and is headquartered in Lutherville, MD | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
BITOECH Consulting SAS
![]() BITOECH Consulting SAS Miscellaneous Commercial ServicesCommercial Services Part of Mabion SA, Biotech Consulting is a French company that provides business consulting services. The company is based in Cornier, France. | Miscellaneous Commercial Services | President | |
NeRRe Therapeutics Ltd.
![]() NeRRe Therapeutics Ltd. Medical DistributorsDistribution Services NeRRe Therapeutics Ltd. provides clinical and pre clinical drugs for treatment of neuronal hypersensitivity. It develops neurokinin receptor antagonists acquired from GlaxoSmithKline. The company was founded by Emiliangelo Ratti and Mike Trower in 2012 and is headquartered in Stevenage, the United Kingdom. | Medical Distributors | Director/Board Member | |
ENYO Pharma SA
![]() ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France. | Biotechnology | Director/Board Member | |
ReViral Ltd.
![]() ReViral Ltd. BiotechnologyHealth Technology ReViral Ltd. specializes in the areas of virology and antiviral therapies. It offers drugs to treat respiratory synctial virus infection. The company was founded by Neil Matthews and Stuart Cockerill in 2011 and is headquartered in Stevenage, the United Kingdom. | Biotechnology | Director/Board Member | |
IKENA ONCOLOGY, INC. | Biotechnology | Director/Board Member | |
Falcon Therapeutics, Inc.
![]() Falcon Therapeutics, Inc. BiotechnologyHealth Technology Falcon Therapeutics, Inc. provides biotechnology services. The company was founded by Karen J. Giroux, Anna M. Seal and Shawn Hingtgen and is headquartered in Chapel Hill, NC. | Biotechnology | Founder | |
Angiex, Inc.
![]() Angiex, Inc. Miscellaneous Commercial ServicesCommercial Services Angiex, Inc. operates as a biotechnology company, which engages in the development of an antibody-drug conjugate therapy for cancer. It focuses on TM4SF1, a membrane glycoprotein of tetraspanin topology that was originally discovered as a protein expressed on many human epithelial tumor cells. The company was founded by Paul Jaminet, Harold Dvorak, and Shou-Ching Jaminet in 2015 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
GHO Capital Partners LLP
![]() GHO Capital Partners LLP Investment ManagersFinance GHO Capital Partners LLP (GHO Capital Partners) is a private equity firm founded in 2014 by Mireille G. Gillings, Dennis B. Gillings, Alan Browning MacKay, Michael Irvine Mortimer and Andrea Ponti. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Private Equity Investor | |
Trawsfynydd Therapeutics, Inc.
![]() Trawsfynydd Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Trawsfynydd Therapeutics, Inc. engages in discovering and developing antiviral medicines. The company is located in the US. | Miscellaneous Commercial Services | Founder | |
KaNDy Therapeutics Ltd.
![]() KaNDy Therapeutics Ltd. BiotechnologyHealth Technology KaNDy Therapeutics Ltd. engages in the provision of a treatment of chronic debilitating female sex-hormone related conditions. Its product is NT-814 a non-hormonal therapy to treat moderate to severe post-menopausal vasomotor symptoms. The company was founded by Dr. Mike Trower and Mary Kerr in 2017 and is headquartered in Stevenage, the United Kingdom. | Biotechnology | Chairman | |
Kartos Therapeutics, Inc.
![]() Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy. | Pharmaceuticals: Major | Founder | |
Gwynant Therapeutics
![]() Gwynant Therapeutics Pharmaceuticals: MajorHealth Technology Gwynant Therapeutics develops new small molecules for oncology targets. | Pharmaceuticals: Major | Director/Board Member | |
NeRRe Therapeutics Holdings Ltd.
![]() NeRRe Therapeutics Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services NeRRe Therapeutics Holdings Ltd. is a British biotechnology company founded in 2017. The private company is based in Stevenage, UK. The company is engaged in research and development of biotechnology. | Miscellaneous Commercial Services | Director/Board Member | |
THESEUS PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer | |
Viriom, Inc.
![]() Viriom, Inc. Miscellaneous Commercial ServicesCommercial Services Viriom, Inc. is a biotechnology company based in San Diego, CA. The company focuses on developing innovative therapies for infectious diseases, including HIV and COVID-19. Viriom's mission is to improve the lives of patients by providing effective and accessible treatments. Iain David Dukes has been the CEO of the company since 2019, leading the team in their efforts to advance the development of their pipeline and bring new therapies to market. | Miscellaneous Commercial Services | Chief Executive Officer |
Statistiques
Internationale
Etats-Unis | 35 |
Royaume-Uni | 10 |
France | 3 |
Allemagne | 2 |
Afrique du Sud | 2 |
Sectorielle
Health Technology | 25 |
Commercial Services | 9 |
Finance | 7 |
Consumer Services | 7 |
Retail Trade | 3 |
Opérationnelle
Director/Board Member | 99 |
Corporate Officer/Principal | 64 |
President | 23 |
Independent Dir/Board Member | 22 |
Chairman | 21 |
Relations les plus connectées
Insiders | |
---|---|
Tadataka Yamada | 36 |
Jim Datin | 34 |
Iain Dukes | 32 |
Richard Kollender | 30 |
Mark Strobeck | 21 |
David W Miller | 14 |
Eric Lefebvre | 13 |
Richard Wallace | 11 |
Seth V. Hetherington | 9 |
William Williams | 8 |
Joseph Zimmermann | 8 |
John Didsbury | 7 |
Anna M. Seal | 7 |
Michel Cimon | 7 |
Jeff Brown | 6 |
- Bourse
- Insiders
- Michael H. Golden
- Connexions Sociétés